Recent Quotes

My Watchlist

Indicators

Overview

Currencies

International

Treasuries

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox

Today 13:00 EST

Via NewMediaWire

Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox

Today 13:00 EST

Via TheNewswire.com

RadNet (RDNT) Q4 2025 Earnings Call Transcript ↗

Today 12:41 EST

Via The Motley Fool

uniQure (NASDAQ:QURE) Stock Plummets 40% Despite Earnings Beat on FDA Setback for AMT-130 ↗

Today 8:23 EST

Via Chartmill

Rixa Health Announces National Expansion of Compound Tirzepatide Solutions to Address Increasing Demand for Metabolic Support

Today 11:39 EST

Via Press Advantage

Zymeworks (ZYME) Q4 2025 Earnings Call Transcript ↗

Today 10:37 EST

Via The Motley Fool

United Therapeutics' Trial Shows 55% Drop in Lung Disease Worsening ↗

Today 10:32 EST

Via Benzinga

Intellia Therapeutics Stock Gains — FDA Lifts Clinical Hold On Pivotal Trial ↗

Today 10:05 EST

Via Benzinga

USDA Deploys $100 Million 'Screwworm Challenge' to Safeguard U.S. Livestock and Dairy Frontier

Today 10:00 EST

Via MarketMinute

uniQure (QURE) Q4 2025 Earnings Call Transcript ↗

Today 9:47 EST

Via The Motley Fool

Rhythm Pharmaceuticals Discloses 18.8% BMI Drop In Rare Obesity Patients ↗

Today 9:41 EST

Via Benzinga

AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗

Today 9:22 EST

Via Stocktwits

Uniqure Plummets More Than 40% On Another Twist In Its Gene Therapy Saga ↗

Today 8:58 EST

Via Investor's Business Daily

Ascendis Wins FDA Approval For Rare Disease Therapy ↗

Today 8:02 EST

Via Benzinga

How can you know if your vehicle has a recall?

Today 8:01 EST

Via Brandpoint

Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗

Today 7:51 EST

Via Stocktwits

Why Did QURE Stock Almost Halve Pre-Market Today? ↗

Today 7:29 EST

Via Stocktwits

BioMarin Strengthens PKU Portfolio With FDA Approval For Younger Patients ↗

Today 6:10 EST

Via Benzinga

Abishai Financial Asia: Apotex Moves Toward Public Offering

Today 4:46 EST

Via AB Newswire

AI.cc’s One API Revolution: How a Startup Slashed AI Budgets by 80% and Accelerated Autonomous Agent Deployment

Today 4:37 EST

Via AB Newswire

Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection ↗

March 01, 2026

Via The Motley Fool

The Sleeper Stock That Could Surge Before Wall Street Notices ↗

March 01, 2026

Via The Motley Fool

Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Lawsuit - Deadline is April 21, 2026

March 01, 2026

Via TheNewswire.com

Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Lawsuit - Deadline is April 21, 2026

March 01, 2026

Via NewMediaWire

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 28, 2026

Via TheNewswire.com

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 28, 2026

Via NewMediaWire

CORT DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit Against Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox

February 28, 2026

Via TheNewswire.com

CORT DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit Against Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox

February 28, 2026

Via NewMediaWire

ADMA Biologics (ADMA) Q4 2025 Earnings Transcript ↗

February 28, 2026

Via The Motley Fool

Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?

February 28, 2026

Via Barchart.com

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.